Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1993 Nov;86(11):642–644. doi: 10.1177/014107689308601111

Delay in presentation after myocardial infarction.

A G Heriot 1, S J Brecker 1, D J Coltart 1
PMCID: PMC1294222  PMID: 8258799

Abstract

Thrombolytic therapy reduces mortality in acute myocardial infarction (AMI), giving maximal benefit with early treatment. In the UK delayed presentation after AMI may reduce the advantages of thrombolysis. To assess this, 103 patients presenting with AMI to two London Hospitals were interviewed to determine the length and cause of delay from onset of chest pain to arrival at hospital. Forty-nine per cent of patients took longer than 2 h to arrive at hospital, and 21% took longer than 4 h. Patients who contacted their general practitioner (GP) had a significantly prolonged time delay (160 mins; 65-730: median; range) compared to those who went directly to hospital by ambulance (82 mins; 15-395; P < 0.0005), or on their own (90 min; 15-855; P < 0.005). Patients calling their GP took a similar duration to decide to seek help [decision time (30 min versus 25 mins) P = NS], but significantly longer to reach hospital once the decision was made (110 min versus 56 min; P < 0.0001), than those proceeding directly to hospital. Believing the pain was cardiac in origin significantly shortened decision time (15 min versus 45 min; P < 0.05), as did knowledge of the existence of thrombolysis (15 min versus 50 min; P < 0.05) and lack of prior cardiac symptoms (18 min versus 42 min; P < 0.05). Only 14% were aware of thrombolysis. Rank correlation confirmed that decision and total delay time were age independent. Delays of this magnitude may compromise the efficiency of thrombolysis.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
643

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armstrong A., Duncan B., Oliver M. F., Julian D. G., Donald K. W., Fulton M., Lutz W., Morrison S. L. Natural history of acute coronary heart attacks. A community study. Br Heart J. 1972 Jan;34(1):67–80. doi: 10.1136/hrt.34.1.67. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bergmann S. R., Lerch R. A., Fox K. A., Ludbrook P. A., Welch M. J., Ter-Pogossian M. M., Sobel B. E. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med. 1982 Oct;73(4):573–581. doi: 10.1016/0002-9343(82)90338-2. [DOI] [PubMed] [Google Scholar]
  3. Burns J. M., Hogg K. J., Rae A. P., Hillis W. S., Dunn F. G. Impact of a policy of direct admission to a coronary care unit on use of thrombolytic treatment. Br Heart J. 1989 Apr;61(4):322–325. doi: 10.1136/hrt.61.4.322. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Colling A., Dellipiani A. W., Donaldson R. J., MacCormack P. Teesside coronary survey: an epidemiological study of acute attacks of myocardial infarction. Br Med J. 1976 Nov 13;2(6045):1169–1172. doi: 10.1136/bmj.2.6045.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dalton H., Chappel D., Climie R. Thrombolysis for acute myocardial infarction in a district general hospital. J R Soc Med. 1989 Jul;82(7):394–395. doi: 10.1177/014107688908200708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Fox K. A. Thrombolysis and the general practitioner. 1. Practicable only under certain circumstances. BMJ. 1990 Mar 31;300(6728):867–868. doi: 10.1136/bmj.300.6728.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Ho M. T., Eisenberg M. S., Litwin P. E., Schaeffer S. M., Damon S. K. Delay between onset of chest pain and seeking medical care: the effect of public education. Ann Emerg Med. 1989 Jul;18(7):727–731. doi: 10.1016/s0196-0644(89)80004-6. [DOI] [PubMed] [Google Scholar]
  8. Kenyon L. W., Ketterer M. W., Gheorghiade M., Goldstein S. Psychological factors related to prehospital delay during acute myocardial infarction. Circulation. 1991 Nov;84(5):1969–1976. doi: 10.1161/01.cir.84.5.1969. [DOI] [PubMed] [Google Scholar]
  9. Koren G., Weiss A. T., Hasin Y., Appelbaum D., Welber S., Rozenman Y., Lotan C., Mosseri M., Sapoznikov D., Luria M. H. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase. N Engl J Med. 1985 Nov 28;313(22):1384–1389. doi: 10.1056/NEJM198511283132204. [DOI] [PubMed] [Google Scholar]
  10. Leitch J. W., Birbara T., Freedman B., Wilcox I., Harris P. J. Factors influencing the time from onset of chest pain to arrival at hospital. Med J Aust. 1989 Jan 2;150(1):6–10. doi: 10.5694/j.1326-5377.1989.tb136310.x. [DOI] [PubMed] [Google Scholar]
  11. Rawles J. M., Haites N. E. Patient and general practitioner delays in acute myocardial infarction. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):882–884. doi: 10.1136/bmj.296.6626.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Reimer K. A., Lowe J. E., Rasmussen M. M., Jennings R. B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation. 1977 Nov;56(5):786–794. doi: 10.1161/01.cir.56.5.786. [DOI] [PubMed] [Google Scholar]
  13. Schmidt S. B., Borsch M. A. The prehospital phase of acute myocardial infarction in the era of thrombolysis. Am J Cardiol. 1990 Jun 15;65(22):1411–1415. doi: 10.1016/0002-9149(90)91345-7. [DOI] [PubMed] [Google Scholar]
  14. Van de Werf F., Arnold A. E. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ. 1988 Nov 26;297(6660):1374–1379. doi: 10.1136/bmj.297.6660.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wielgosz A. T., Nolan R. P., Earp J. A., Biro E., Wielgosz M. B. Reasons for patients' delay in response to symptoms of acute myocardial infarction. CMAJ. 1988 Nov 1;139(9):853–857. [PMC free article] [PubMed] [Google Scholar]
  16. Wilcox R. G. Thrombolysis and the general practitioner. 2. Useful after careful evaluation of patients. BMJ. 1990 Mar 31;300(6728):869–870. doi: 10.1136/bmj.300.6728.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES